NCT06248307Completed
Evaluation of Protein Bars on Weight Management and Osteoarthicular Health
Evaluación Del Efecto de la Ingesta de Una Barrita Con Alto Contenido de proteína Sobre el Peso y la Salud Osteoarticular
Source: ClinicalTrials.gov · Last updated 25 Sept 2024
Brief summary (registry, in English)
The goal of this intervention study is to evaluate the efficacy in subjects with overweight or obesity of protein bars consumption. The main questions it aims to answer are: * Does the regular consumption of these protein bars help to loose weight? * Does the regular consumption of these protein bars help to improve the osteoarticular health? Participants will be asked to follow the indications of consumption of the bars togather with healthy nutritional advice during 16 weeks. Researchers will compare exparimental Versus placebo groups to see if weight is lost in similar or different ways.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 102 (actual)
- First submitted
- 30 Jan 2024
- Start date
- 15 Nov 2023
- Primary completion date
- 30 Jul 2024
- Lead sponsor
- Clinica Universidad de Navarra, Universidad de Navarra
- Diseases
- Obesity
- NCT number
- NCT06248307
What you commit to
- Study type: Interventional
- Participants enrolled: 102
- From 15 Nov 2023 to the primary completion date, 30 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Bariatric surgery or similar
Other illness
- Any funcitonal or structural impairment in digestive system (hitus hernia, ulcers, inflammatory bowel disease, etc.)
- Arthritis, hepatic diseases, cancer.
- Subjects presenting any cognitive or psichiatric impairment, that may impel them to follow the protocol.
Other
- Excessive alcohol consumption (\> 14 units/week in women and \> 20 units per week in men)
- Alergy to any component of the products
- Subjects following any weight loss program
Who the study is looking for
- BMI between 25 and 37.5 kg/m2
- Normal physical examination and vital signs according to clinical examiners.
- Chronic pharmacological treatment is permitted if dosage is stable within at least three months prior the start of the intervention.
Age in the registry: 35 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centro de Investigacion en Nutricion. Universidad de Navarra Coordinator of this site? Confirm its status | Pamplona | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.